Print

IAVI 004

A double-blind, randomised placebo-controlled phase I trial to evaluate the safety and immunogenicity of a candidate HIV-1 MVA vaccine, MVA.HIVA, delivered intradermally by a needle injection in healthy HIV-vaccine-na?ve, HIV-uninfected adult Kenyan male and female volunteers

Trial Details:

I Completed
Kenya AIDS Vaccine Initiative (KAVI), International AIDS Vaccine Initiative (IAVI) February 06, 2002
MVA.HIVA Gag A
MVA.HIVA Viral Vector - Pox
Kenya 18
http://www.iavi.org